Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients

Annals of Thoracic Surgery

Volumn 94, Issue 6, 2012, Pages 1954-1960

  Osnabrugge, Ruben L J ^a   Head, Stuart J ^a   Genders, Tessa S S ^a   Van Mieghem, Nicolas M ^a   De Jaegere, Peter P T ^a   Van Der Boon, Robert M A ^a   Kerkvliet, J Marco ^a   Kalesan, Bindu ^b   Bogers, Ad J J C ^a   Kappetein, A Pieter ^a   Hunink, M G Myriam ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BLOOD; BOOTSTRAPPING; CATHETER VALVE; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATING ROOM; PATIENT; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; NETHERLANDS; PROPENSITY SCORE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84869994268     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.07.002     Document Type: Article

References (25)

1. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. C.R. Smith, M.B. Leon, M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
3. J.H. Calhoon Relative value of transcatheter aortic valve replacement Ann Thorac Surg 93 2012 1023 1024
4. M.R. Reynolds New analysis measures cost-effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement http://www.nxtbook.com/nxtbooks/md-conference-express/tct2011/index.php?startid= 5#/4 Transcatheter Cardiovascular Therapeutics 2011. Accessed January 3, 2012
5. S.J. Head, A.J.J.C. Bogers, P.W. Serruys, J.J.M. Takkenberg, A.P. Kappetein A crucial factor in shared decision making: the team approach Lancet 377 2011 1836
6. R.L. Osnabrugge, S.J. Head, A.J.J.C. Bogers, A.P. Kappetein Patient selection for transcatheter aortic valve replacement: what does the future hold? Expert Rev Cardiovasc Ther 10 2012 678 679
7. CVZ Dutch manual for cost-analyses [in Dutch] 2010 Dutch Health Care Insurance Board
8. Dutch Consumer Price Indices 2011 Central Statistics Bureau, The Netherlands http://statline.cbs.nl Accessed January 10, 2012
9. G. Heinze, P. Juni An overview of the objectives of and the approaches to propensity score analyses Eur Heart J 32 2011 1704 1708
10. P.R. Rosenbaum, D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
11. D.B. Rubin Bias reduction using Mahalanobis-metric matching Biometrics 36 1980 293 298
12. A. Briggs, T. Clark, J. Wolstenholme, P. Clarke Missing...presumed at random: cost-analysis of incomplete data Health Econ 12 2003 377 392
13. S. Ramsey, R. Willke, A. Briggs Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report Value Health 8 2005 521 533
14. K. Bollen, R. Jackman Regression diagnostics: an expository treatment of outliers and influential cases S.L.J. Fox J, Modern methods of data analysis 1990 Sage Newbury Park, CA 257 291
15. W. Wijns, P. Kolh, N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
16. V.H. Thourani, W.S. Weintraub, J.M. Craver, E.L. Jones, E.M. Mahoney, R.A. Guyton Ten-year trends in heart valve replacement operations Ann Thorac Surg 70 2000 448 455
17. M. Abdel-Wahab, A.E. Mostafa, V. Geist Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention Am J Cardiol 109 2011 581 586
18. A. Brown, B.J. Meenan, T.P. Young Marketing innovation: medical device prices follow the experience curve Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 7 2007 203 212
19. M. Watt, S. Mealing, J. Eaton Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement Heart 98 2011 370 376
20. Y.X. Wu, R.Y. Jin, G.Q. Gao, G.L. Grunkemeier, A. Starr Cost-effectiveness of aortic valve replacement in the elderly: an introductory study J Thorac Cardiovasc Surg 133 2007 608 613
21. G.F. Anderson, U.E. Reinhardt, P.S. Hussey, V. Petrosyan It's the prices, stupid: why the United States is so different from other countries Health Aff (Millwood) 22 2003 89 105
22. P. Farahani, M. Levine, R. Goeree A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics J Eval Clin Pract 12 2006 463 470
23. C.M. Bell, D.R. Urbach, J.G. Ray Bias in published cost-effectiveness studies: systematic review BMJ 332 2006 699 703
24. E.L. Hannan, Z. Samadashvili, K. Cozzens Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York Circulation 125 2012 1870 1879
25. M.F. Drummond, B.S. Bloom, G. Carrin Issues in the cross-national assessment of health technology Int J Technol Assess Health Care 8 1992 671 682